top of page

Search

June 27th! You're invited! Zynlonta: CD-19-direct ADC for 3L DLBCL

Jun 20, 2023
0 min read

Recent Posts

Emerging Clinical Evidence for the Use of ENHERTU in HER2+ Breast Cancer ~ 7/29/26

Emerging Clinical Evidence for the Use of ENHERTU in HER2+ Breast Cancer ~ 7/29/26

NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress

NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress

NEW EVENT! An Approved Trop2-Directed ADC forAdults With Previously Treated HR+/HER2–(IHC 0, IHC 1+ or IHC 2+/ISH–) MetastaticBreast Cancer - May 13th!

NEW EVENT! An Approved Trop2-Directed ADC forAdults With Previously Treated HR+/HER2–(IHC 0, IHC 1+ or IHC 2+/ISH–) MetastaticBreast Cancer - May 13th!

Comments

bottom of page